Kodiak Sciences KOD
NASDAQ KOD
$98.46 +3.66 (+3.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kodiak Sciences (KOD) Return on Equity [ROE] (2019 - 2026)

Updated

Kodiak Sciences (KOD) posted Return on Equity [ROE] of -279.28% for Q2 2026, down 56.30 percentage points from -222.98% a year earlier and down 108.18 percentage points from the prior quarter.

Analysis

Kodiak Sciences (KOD) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Kodiak Sciences' Return on Equity [ROE] came in at -149.43%, down 64.97 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for six consecutive years, with a five-year change of -127.36 percentage points (FY2020 to FY2025).
  • In prior years, Kodiak Sciences' Return on Equity [ROE] was -84.46% in FY2024 (-10.21 pp), -74.25% in FY2023 (-13.44 pp), -60.81% in FY2022 (-25.80 pp) and -35.01% in FY2021 (-12.95 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -462.27% in Q3 2025 to a high of -29.25% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last 19 quarters, with an average year-over-year change of -101.46 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2021, with a gain of 5.38 percentage points; the weakest was Q3 2025, with a drop of 366.67 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -171.09% (Q1 2026), -253.90% (Q4 2025) and -462.27% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Kodiak Sciences 5.96 Bn 5.96 Bn - -279.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -279.28%
Mar 31, 2026 -171.09%
Dec 31, 2025 -253.90%
Sep 30, 2025 -462.27%
Jun 30, 2025 -222.98%
Mar 31, 2025 -147.01%
Dec 31, 2024 -104.69%
Sep 30, 2024 -95.59%
Jun 30, 2024 -86.54%
Mar 31, 2024 -91.64%
Dec 31, 2023 -91.73%
Sep 30, 2023 -84.94%
Jun 30, 2023 -81.85%
Mar 31, 2023 -74.72%
Dec 31, 2022 -73.02%
Sep 30, 2022 -70.53%
Jun 30, 2022 -61.48%
Mar 31, 2022 -49.51%
Dec 31, 2021 -38.40%
Sep 30, 2021 -29.25%
API Access

Kodiak Sciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KOD&period=max&api_key=YOUR_API_KEY